Exagen announces acceptance of multiple abstracts at acr 2022 annual meeting

San diego, sept. 20, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced today the acceptance of nine abstracts at the 2022 american college of rheumatology's (acr) annual meeting, acr convergence 2022, being held november 10-14, 2022, at the pennsylvania convention center in philadelphia, pennsylvania.
XGN Ratings Summary
XGN Quant Ranking